⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2161853 | 0.82 | — | — | |
| SCHEMBL194120 | 0.74 | — | — | |
| SCHEMBL6060235 | 0.72 | — | — | |
| SCHEMBL3101799 | 0.69 | — | — | |
| SCHEMBL2105710 | 0.68 | — | — | |
| SCHEMBL62396 | 0.67 | — | — | |
| SCHEMBL16544543 | 0.67 | — | — | |
| SCHEMBL5986595 | 0.65 | — | — | |
| SCHEMBL4119428 | 0.64 | — | — | |
| SCHEMBL5985489 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1661882-B1 | Compound having anti-HCV activity and process for producing the same | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2013-10-30 | — | — | EP | disclosed |
| US-8183005-B1 | Pharmaceutical agents for treating HCV infections | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2012-05-22 | — | — | US | disclosed |
| US-20110160252-A1 | PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OR PREVENTION OF HBV INFECTION | PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY (JP) | 2011-06-30 | — | — | US | disclosed |
| EP-2305234-A1 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF HBV INFECTION | Public University Corporation Nagoya City University (JP) | 2011-04-06 | — | — | EP | disclosed |
| EP-2042188-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING HCV INFECTION | Tokyo Metropolitan Organization for Medical Research (JP) | 2009-04-01 | — | — | EP | disclosed |
| US-7378446-B2 | Compound having anti-HCV activity and process for producing the same | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2008-05-27 | — | — | US | disclosed |
| EP-1795206-A1 | DRUG FOR TREATING OR PREVENTING HCV INFECTION | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2007-06-13 | — | — | EP | disclosed |
| US-20060194870-A1 | Compound having anti-hcv activity and process for producing the same | CHUGAI SEIYAKU KABUSHIKI KAISHA | 2006-08-31 | — | — | US | disclosed |
| EP-1661882-A1 | COMPOUND HAVING ANTI-HCV ACTIVITY AND PROCESS FOR PRODUCING THE SAME | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2006-05-31 | — | — | EP | disclosed |